Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gut microbiota composition in travellers is associated with faecal lipocalin-2, a mediator of gut inflammation.
Gandasegui J, Vergara A, Fleitas P, Rubio E, Fernandez-Pittol M, Aylagas C, Alvarez M, Zancada N, Camprubí-Ferrer D, Vila J, Muñoz J, Petrone P, Casals-Pascual C. Gandasegui J, et al. Among authors: fleitas p. Front Cell Infect Microbiol. 2024 Apr 26;14:1387126. doi: 10.3389/fcimb.2024.1387126. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38736752 Free PMC article.
Moxidectin versus ivermectin for strongyloidiasis control.
Gandasegui J, Muñoz J, Fleitas P, Mazzi C, Bisoffi Z. Gandasegui J, et al. Among authors: fleitas p. Lancet Infect Dis. 2024 Mar;24(3):e152. doi: 10.1016/S1473-3099(23)00823-X. Epub 2024 Jan 15. Lancet Infect Dis. 2024. PMID: 38237614 No abstract available.
Host biomarkers for early identification of severe imported Plasmodium falciparum malaria.
Balerdi-Sarasola L, Parolo C, Fleitas P, Cruz A, Subirà C, Rodríguez-Valero N, Almuedo-Riera A, Letona L, Álvarez-Martínez MJ, Valls ME, Vera I, Mayor A, Muñoz J, Camprubí-Ferrer D. Balerdi-Sarasola L, et al. Among authors: fleitas p. Travel Med Infect Dis. 2023 Jul-Aug;54:102608. doi: 10.1016/j.tmaid.2023.102608. Epub 2023 Jun 20. Travel Med Infect Dis. 2023. PMID: 37348666 Free article.
An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol.
Krolewiecki A, Enbiale W, Gandasegui J, van Lieshout L, Kepha S, Messa Junior A, Bengtson M, Gelaye W, Escola V, Martinez-Valladares M, Cambra-Pellejà M, Algorta J, Martí-Soler H, Fleitas P, Ballester MR, Doyle SR, Williams NA, Legarda A, Mandomando I, Mwandawiro C, Muñoz J. Krolewiecki A, et al. Among authors: fleitas p. Gates Open Res. 2022 May 5;6:62. doi: 10.12688/gatesopenres.13615.1. eCollection 2022. Gates Open Res. 2022. PMID: 36540062 Free PMC article.
Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients.
Mayer MA, Krolewiecki A, Ferrero A, Bocchio M, Barbero J, Miguel M, Paladini A, Delgado C, Ojeda JR, Elorza C, Bertone A, Fleitas PE, Vera G, Kohan MR. Mayer MA, et al. Among authors: fleitas pe. Front Public Health. 2022 Feb 22;10:813378. doi: 10.3389/fpubh.2022.813378. eCollection 2022. Front Public Health. 2022. PMID: 35273939 Free PMC article.
19 results